tiprankstipranks
Aurinia Pharmaceuticals (AUPH)
NASDAQ:AUPH
Holding AUPH?
Track your performance easily

Aurinia Pharmaceuticals (AUPH) Financial Statements

1,994 Followers

Aurinia Pharmaceuticals Financial Overview

Aurinia Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.158; its P/E ratio is -55.51; Aurinia Pharmaceuticals is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $0.03. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 67.77M$ 57.19M$ 50.30M$ 45.09M$ 54.52M
Gross Profit$ 61.74M$ 48.28M$ 42.55M$ 39.70M$ 47.75M
EBIT$ 16.02M$ 2.68M$ -8.73M$ -25.11M$ -11.75M
EBITDA$ 17.49M$ 4.39M$ -7.09M$ -23.46M$ -9.72M
Net Income Common Stockholders$ 14.35M$ 722.00K$ -10.75M$ -26.88M$ -13.45M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 348.75M$ 330.48M$ 319.91M$ 350.49M$ 337.90M
Total Assets$ 549.36M$ 523.53M$ 516.63M$ 548.06M$ 555.01M
Total Debt$ 87.85M$ 85.98M$ 88.54M$ 97.61M$ 93.21M
Net Debt$ -260.90M$ -244.49M$ -231.38M$ -252.88M$ -244.69M
Total Liabilities$ 161.36M$ 158.91M$ 157.16M$ 170.11M$ 163.14M
Stockholders Equity$ 388.00M$ 364.62M$ 359.48M$ 377.95M$ 391.88M
Cash Flow-
Free Cash Flow$ 16.90M$ 15.76M$ -18.61M$ 14.25M$ -13.20M
Operating Cash Flow$ 17.03M$ 15.84M$ -18.60M$ 14.31M$ -13.28M
Investing Cash Flow$ -10.57M$ -38.62M$ 49.23M$ -6.26M$ -19.70M
Financing Cash Flow$ -2.72M$ -8.27M$ -15.05M$ -5.58M$ -2.33M
Currency in USD

Aurinia Pharmaceuticals Earnings and Revenue History

Aurinia Pharmaceuticals Debt to Assets

Aurinia Pharmaceuticals Cash Flow

Aurinia Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis